Personal Injury Law

Pfizer pulls Thelin from consumer markets, citing Liver damage.

By Hurley, McKenna & Mertz

Pfizer, Inc. says ?it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage.? (NY AP, 12/10).

The drug, Thelin has been sold in Europe, Canada, and Australia as treatment for ?pulmonary arterial hypertension? ? high blood pressure in the pulmonary artery.
Although Liver toxicity was known to be a side effect of Thelin, a new review of clinical trial data lead to the discovery of a new link to severe livery injury. This link led to the drug being pulled from consumer markets.

Because other treatment options are available, Pfizer says ?the benefits of Thelin don't outweigh the risks?[so] It is stopping all studies of the oral drug.? As a Chicago products liability attorney, with medical malpractice experience, I am pleased to see Pfizer taking the necessary steps to remove unsafe drugs from the market.

Full post as published by Chicago Medical Malpractice Lawyer Blog on December 12, 2010 (boomark / email).